�ݺ�ߣshows by User: CHANDANAC24

�ݺ�ߣshows by User: CHANDANAC24 / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: CHANDANAC24 / Fri, 09 Dec 2022 15:39:07 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: CHANDANAC24 Drug disposal brochure /slideshow/drug-disposal-brochure-254841937/254841937 drugdisposalbrochure-221209153907-dfad09fc
PROPER DISPOSAL OF UNUSED MEDICINES Properly getting rid of unused or expired medicine protects people, animals, and the environment. Use drug take-back system Do Flushing to toilet/sink Dispose with household trash Return back to health care professionals (Pharmacist) Store medicine as per label Keep medicine in a cool, dry place that is out of the reach of children Lock up medicine in a cabinet, drawer, or in safe place Store in the original container, which has information about the medicine Discuss with your pharmacist about proper storage of medications with respect to dosage form. Don’t use liquid medications like syrup, ear drops, eye drops after they are crystallised Don’t store medicine in a bathroom, Kitchen where humidity and temperature changes can cause damage Don’t share your prescription medicine with anyone - a medicine that works for you may cause harm, even death, to someone else. PROPER DISPOSAL OF UNUSED MEDICINES Properly getting rid of unused or expired medicine protects people, animals, and the environment. ]]>
PROPER DISPOSAL OF UNUSED MEDICINES Properly getting rid of unused or expired medicine protects people, animals, and the environment. Use drug take-back system Do Flushing to toilet/sink Dispose with household trash Return back to health care professionals (Pharmacist) Store medicine as per label Keep medicine in a cool, dry place that is out of the reach of children Lock up medicine in a cabinet, drawer, or in safe place Store in the original container, which has information about the medicine Discuss with your pharmacist about proper storage of medications with respect to dosage form. Don’t use liquid medications like syrup, ear drops, eye drops after they are crystallised Don’t store medicine in a bathroom, Kitchen where humidity and temperature changes can cause damage Don’t share your prescription medicine with anyone - a medicine that works for you may cause harm, even death, to someone else. PROPER DISPOSAL OF UNUSED MEDICINES Properly getting rid of unused or expired medicine protects people, animals, and the environment. ]]> Fri, 09 Dec 2022 15:39:07 GMT /slideshow/drug-disposal-brochure-254841937/254841937 CHANDANAC24@slideshare.net(CHANDANAC24) Drug disposal brochure CHANDANAC24 PROPER DISPOSAL OF UNUSED MEDICINES Properly getting rid of unused or expired medicine protects people, animals, and the environment. Use drug take-back system Do Flushing to toilet/sink Dispose with household trash Return back to health care professionals (Pharmacist) Store medicine as per label Keep medicine in a cool, dry place that is out of the reach of children Lock up medicine in a cabinet, drawer, or in safe place Store in the original container, which has information about the medicine Discuss with your pharmacist about proper storage of medications with respect to dosage form. Don’t use liquid medications like syrup, ear drops, eye drops after they are crystallised Don’t store medicine in a bathroom, Kitchen where humidity and temperature changes can cause damage Don’t share your prescription medicine with anyone - a medicine that works for you may cause harm, even death, to someone else. PROPER DISPOSAL OF UNUSED MEDICINES Properly getting rid of unused or expired medicine protects people, animals, and the environment. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/drugdisposalbrochure-221209153907-dfad09fc-thumbnail.jpg?width=120&height=120&fit=bounds" /> PROPER DISPOSAL OF UNUSED MEDICINES Properly getting rid of unused or expired medicine protects people, animals, and the environment. Use drug take-back system Do Flushing to toilet/sink Dispose with household trash Return back to health care professionals (Pharmacist) Store medicine as per label Keep medicine in a cool, dry place that is out of the reach of children Lock up medicine in a cabinet, drawer, or in safe place Store in the original container, which has information about the medicine Discuss with your pharmacist about proper storage of medications with respect to dosage form. Don’t use liquid medications like syrup, ear drops, eye drops after they are crystallised Don’t store medicine in a bathroom, Kitchen where humidity and temperature changes can cause damage Don’t share your prescription medicine with anyone - a medicine that works for you may cause harm, even death, to someone else. PROPER DISPOSAL OF UNUSED MEDICINES Properly getting rid of unused or expired medicine protects people, animals, and the environment.

Drug disposal brochure from CHANDANAC24

]]> 21 0 https://cdn.slidesharecdn.com/ss_thumbnails/drugdisposalbrochure-221209153907-dfad09fc-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 SEIZURE,TYPE II DIABETES MELIITUS /CHANDANAC24/seizuretype-ii-diabetes-meliitus iv-221209153247-1fcc2c8e
SEIZURE,TYPE II DIABETES MELIITUS]]>
SEIZURE,TYPE II DIABETES MELIITUS]]> Fri, 09 Dec 2022 15:32:47 GMT /CHANDANAC24/seizuretype-ii-diabetes-meliitus CHANDANAC24@slideshare.net(CHANDANAC24) SEIZURE,TYPE II DIABETES MELIITUS CHANDANAC24 SEIZURE,TYPE II DIABETES MELIITUS <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/iv-221209153247-1fcc2c8e-thumbnail.jpg?width=120&height=120&fit=bounds" /> SEIZURE,TYPE II DIABETES MELIITUS

SEIZURE,TYPE II DIABETES MELIITUS from CHANDANAC24

]]> 81 0 https://cdn.slidesharecdn.com/ss_thumbnails/iv-221209153247-1fcc2c8e-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 GASTROENTERITIS /slideshow/gastroenteritis-254841833/254841833 iv-221209153130-d66435a1
GASTROENTERITIS]]>
GASTROENTERITIS]]> Fri, 09 Dec 2022 15:31:30 GMT /slideshow/gastroenteritis-254841833/254841833 CHANDANAC24@slideshare.net(CHANDANAC24) GASTROENTERITIS CHANDANAC24 GASTROENTERITIS <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/iv-221209153130-d66435a1-thumbnail.jpg?width=120&height=120&fit=bounds" /> GASTROENTERITIS

GASTROENTERITIS from CHANDANAC24

]]> 511 0 https://cdn.slidesharecdn.com/ss_thumbnails/iv-221209153130-d66435a1-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 MIGRAINE, CVT /CHANDANAC24/migraine-cvt iv-221209152908-73781b96
Cerebral venous thrombosis is the cerebral vein thrombosis of dural sinus and/or cerebral veins. The incidence of cerebral venous thrombosis is estimated at 0.2-0.5/1 lakh/year. 0.39 deaths/million of 56million population. The mortality of CVT probably varied b/w 20% and 50%. Inherited thrombophilia:- prothrombin gene mutation, protein S and C deficiency, ant thrombin deficinecy,dysfibrogenemia Vascular injury:- nephrotic syndrome Medication:- estrogen, heparin Other medical illness:- CHF, IBD, HIV,Surgery, Trauma. Age:- Above 50 years Surgery Accidents Medications Vascular injury Pregnancy Other medical illness:- CHF, IBD, HIV Isolated intracranial hypertension syndrome: headache, vomiting, papilledema, visual disturbance Focal syndrome :- focal deficits, seizures (focal/generalized) or both Encephalopathy:- multifocal signs, mental status changes, stupor or coma. Venous infarction Haemorrhage Subarachnoid haemorrhage Pulmonary embolism Epilepsy ]]>
Cerebral venous thrombosis is the cerebral vein thrombosis of dural sinus and/or cerebral veins. The incidence of cerebral venous thrombosis is estimated at 0.2-0.5/1 lakh/year. 0.39 deaths/million of 56million population. The mortality of CVT probably varied b/w 20% and 50%. Inherited thrombophilia:- prothrombin gene mutation, protein S and C deficiency, ant thrombin deficinecy,dysfibrogenemia Vascular injury:- nephrotic syndrome Medication:- estrogen, heparin Other medical illness:- CHF, IBD, HIV,Surgery, Trauma. Age:- Above 50 years Surgery Accidents Medications Vascular injury Pregnancy Other medical illness:- CHF, IBD, HIV Isolated intracranial hypertension syndrome: headache, vomiting, papilledema, visual disturbance Focal syndrome :- focal deficits, seizures (focal/generalized) or both Encephalopathy:- multifocal signs, mental status changes, stupor or coma. Venous infarction Haemorrhage Subarachnoid haemorrhage Pulmonary embolism Epilepsy ]]> Fri, 09 Dec 2022 15:29:08 GMT /CHANDANAC24/migraine-cvt CHANDANAC24@slideshare.net(CHANDANAC24) MIGRAINE, CVT CHANDANAC24 Cerebral venous thrombosis is the cerebral vein thrombosis of dural sinus and/or cerebral veins. The incidence of cerebral venous thrombosis is estimated at 0.2-0.5/1 lakh/year. 0.39 deaths/million of 56million population. The mortality of CVT probably varied b/w 20% and 50%. Inherited thrombophilia:- prothrombin gene mutation, protein S and C deficiency, ant thrombin deficinecy,dysfibrogenemia Vascular injury:- nephrotic syndrome Medication:- estrogen, heparin Other medical illness:- CHF, IBD, HIV,Surgery, Trauma. Age:- Above 50 years Surgery Accidents Medications Vascular injury Pregnancy Other medical illness:- CHF, IBD, HIV Isolated intracranial hypertension syndrome: headache, vomiting, papilledema, visual disturbance Focal syndrome :- focal deficits, seizures (focal/generalized) or both Encephalopathy:- multifocal signs, mental status changes, stupor or coma. Venous infarction Haemorrhage Subarachnoid haemorrhage Pulmonary embolism Epilepsy <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/iv-221209152908-73781b96-thumbnail.jpg?width=120&height=120&fit=bounds" /> Cerebral venous thrombosis is the cerebral vein thrombosis of dural sinus and/or cerebral veins. The incidence of cerebral venous thrombosis is estimated at 0.2-0.5/1 lakh/year. 0.39 deaths/million of 56million population. The mortality of CVT probably varied b/w 20% and 50%. Inherited thrombophilia:- prothrombin gene mutation, protein S and C deficiency, ant thrombin deficinecy,dysfibrogenemia Vascular injury:- nephrotic syndrome Medication:- estrogen, heparin Other medical illness:- CHF, IBD, HIV,Surgery, Trauma. Age:- Above 50 years Surgery Accidents Medications Vascular injury Pregnancy Other medical illness:- CHF, IBD, HIV Isolated intracranial hypertension syndrome: headache, vomiting, papilledema, visual disturbance Focal syndrome :- focal deficits, seizures (focal/generalized) or both Encephalopathy:- multifocal signs, mental status changes, stupor or coma. Venous infarction Haemorrhage Subarachnoid haemorrhage Pulmonary embolism Epilepsy

MIGRAINE, CVT from CHANDANAC24

]]> 13 0 https://cdn.slidesharecdn.com/ss_thumbnails/iv-221209152908-73781b96-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 ANEMIA /slideshow/anemia-254841792/254841792 iv-221209152629-c5e8da7b
Anaemia is a condition where there is a decrease in the total amount of red blood cells in or haemoglobin in the blood or a lowered ability of the blood to carry oxygen. ETIOLOGY :blood loss and decreased red blood cell production. SYMPTOMS : feeling tired, weakness, shortness of breath. EPIDEMIOLOGY: Anaemia is a common, multifactorial condition among older adults. RISK FACTORS :chronic infections such as osteomyelitis , SLE COMPLICATIONS : lack of energy, increased risk of infections, heart and lung problems ]]>
Anaemia is a condition where there is a decrease in the total amount of red blood cells in or haemoglobin in the blood or a lowered ability of the blood to carry oxygen. ETIOLOGY :blood loss and decreased red blood cell production. SYMPTOMS : feeling tired, weakness, shortness of breath. EPIDEMIOLOGY: Anaemia is a common, multifactorial condition among older adults. RISK FACTORS :chronic infections such as osteomyelitis , SLE COMPLICATIONS : lack of energy, increased risk of infections, heart and lung problems ]]> Fri, 09 Dec 2022 15:26:29 GMT /slideshow/anemia-254841792/254841792 CHANDANAC24@slideshare.net(CHANDANAC24) ANEMIA CHANDANAC24 Anaemia is a condition where there is a decrease in the total amount of red blood cells in or haemoglobin in the blood or a lowered ability of the blood to carry oxygen. ETIOLOGY :blood loss and decreased red blood cell production. SYMPTOMS : feeling tired, weakness, shortness of breath. EPIDEMIOLOGY: Anaemia is a common, multifactorial condition among older adults. RISK FACTORS :chronic infections such as osteomyelitis , SLE COMPLICATIONS : lack of energy, increased risk of infections, heart and lung problems <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/iv-221209152629-c5e8da7b-thumbnail.jpg?width=120&height=120&fit=bounds" /> Anaemia is a condition where there is a decrease in the total amount of red blood cells in or haemoglobin in the blood or a lowered ability of the blood to carry oxygen. ETIOLOGY :blood loss and decreased red blood cell production. SYMPTOMS : feeling tired, weakness, shortness of breath. EPIDEMIOLOGY: Anaemia is a common, multifactorial condition among older adults. RISK FACTORS :chronic infections such as osteomyelitis , SLE COMPLICATIONS : lack of energy, increased risk of infections, heart and lung problems

ANEMIA from CHANDANAC24

]]> 472 0 https://cdn.slidesharecdn.com/ss_thumbnails/iv-221209152629-c5e8da7b-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 SPONDYLOSIS AND GASTROENTERITIES /slideshow/spondylosis-and-gastroenterities/254841692 iii-221209151034-1487eda2
SPONDYLOSIS AND GASTROENTERITIES INTRODUCTION:- Spondylosis (spinal osteoarthritis) is a degenerative disorder It may affect the cervical(neck), thoracic(mid-back), lumbar(low-back) regions of the spine It may cause loss of normal spinal shape and function Commonly seen in individuals after the age of 40 years Spondylosis refers to the degenerative changes in the spine such as bone spurs and degenerating intervertebral discs Spondylosis changes in the spine are frequently referred to as osteoarthritis Degeneration of cervical intervertebral disc and the secondary degeneration of cervical intervertebral joints, leads to injury of spinal cord, nerve roots and vertebral artery, and shows corresponding signs and symptoms Lumbar spondylosis:- Lumbar spondylosis is a medical condition in which chronic pain is experienced by the patient in the lumbar region (lower back) due to compression of the intervertebral discs Age:- The discs are dehydrate, become thinner and become harder, then provide less support to the vertebrae resting on the discs Repetitive strain injury (RSI) caused to lifestyle like driving, travelling, intense work in farm, who carry loads on their head Congenital deformity:- stenosis of cervical spinal canal Genetics:- if family has history Mental health :- depression, anxiety]]>
SPONDYLOSIS AND GASTROENTERITIES INTRODUCTION:- Spondylosis (spinal osteoarthritis) is a degenerative disorder It may affect the cervical(neck), thoracic(mid-back), lumbar(low-back) regions of the spine It may cause loss of normal spinal shape and function Commonly seen in individuals after the age of 40 years Spondylosis refers to the degenerative changes in the spine such as bone spurs and degenerating intervertebral discs Spondylosis changes in the spine are frequently referred to as osteoarthritis Degeneration of cervical intervertebral disc and the secondary degeneration of cervical intervertebral joints, leads to injury of spinal cord, nerve roots and vertebral artery, and shows corresponding signs and symptoms Lumbar spondylosis:- Lumbar spondylosis is a medical condition in which chronic pain is experienced by the patient in the lumbar region (lower back) due to compression of the intervertebral discs Age:- The discs are dehydrate, become thinner and become harder, then provide less support to the vertebrae resting on the discs Repetitive strain injury (RSI) caused to lifestyle like driving, travelling, intense work in farm, who carry loads on their head Congenital deformity:- stenosis of cervical spinal canal Genetics:- if family has history Mental health :- depression, anxiety]]> Fri, 09 Dec 2022 15:10:34 GMT /slideshow/spondylosis-and-gastroenterities/254841692 CHANDANAC24@slideshare.net(CHANDANAC24) SPONDYLOSIS AND GASTROENTERITIES CHANDANAC24 SPONDYLOSIS AND GASTROENTERITIES INTRODUCTION:- Spondylosis (spinal osteoarthritis) is a degenerative disorder It may affect the cervical(neck), thoracic(mid-back), lumbar(low-back) regions of the spine It may cause loss of normal spinal shape and function Commonly seen in individuals after the age of 40 years Spondylosis refers to the degenerative changes in the spine such as bone spurs and degenerating intervertebral discs Spondylosis changes in the spine are frequently referred to as osteoarthritis Degeneration of cervical intervertebral disc and the secondary degeneration of cervical intervertebral joints, leads to injury of spinal cord, nerve roots and vertebral artery, and shows corresponding signs and symptoms Lumbar spondylosis:- Lumbar spondylosis is a medical condition in which chronic pain is experienced by the patient in the lumbar region (lower back) due to compression of the intervertebral discs Age:- The discs are dehydrate, become thinner and become harder, then provide less support to the vertebrae resting on the discs Repetitive strain injury (RSI) caused to lifestyle like driving, travelling, intense work in farm, who carry loads on their head Congenital deformity:- stenosis of cervical spinal canal Genetics:- if family has history Mental health :- depression, anxiety <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/iii-221209151034-1487eda2-thumbnail.jpg?width=120&height=120&fit=bounds" /> SPONDYLOSIS AND GASTROENTERITIES INTRODUCTION:- Spondylosis (spinal osteoarthritis) is a degenerative disorder It may affect the cervical(neck), thoracic(mid-back), lumbar(low-back) regions of the spine It may cause loss of normal spinal shape and function Commonly seen in individuals after the age of 40 years Spondylosis refers to the degenerative changes in the spine such as bone spurs and degenerating intervertebral discs Spondylosis changes in the spine are frequently referred to as osteoarthritis Degeneration of cervical intervertebral disc and the secondary degeneration of cervical intervertebral joints, leads to injury of spinal cord, nerve roots and vertebral artery, and shows corresponding signs and symptoms Lumbar spondylosis:- Lumbar spondylosis is a medical condition in which chronic pain is experienced by the patient in the lumbar region (lower back) due to compression of the intervertebral discs Age:- The discs are dehydrate, become thinner and become harder, then provide less support to the vertebrae resting on the discs Repetitive strain injury (RSI) caused to lifestyle like driving, travelling, intense work in farm, who carry loads on their head Congenital deformity:- stenosis of cervical spinal canal Genetics:- if family has history Mental health :- depression, anxiety

SPONDYLOSIS AND GASTROENTERITIES from CHANDANAC24

]]> 325 0 https://cdn.slidesharecdn.com/ss_thumbnails/iii-221209151034-1487eda2-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 CASE PRESENTATION ON LEG CELLULITIS /CHANDANAC24/case-presentation-on-leg-cellulitis iii-221209150910-1d9a7b7c
CASE PRESENTATION ON LEG CELLULITIS]]>
CASE PRESENTATION ON LEG CELLULITIS]]> Fri, 09 Dec 2022 15:09:10 GMT /CHANDANAC24/case-presentation-on-leg-cellulitis CHANDANAC24@slideshare.net(CHANDANAC24) CASE PRESENTATION ON LEG CELLULITIS CHANDANAC24 CASE PRESENTATION ON LEG CELLULITIS <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/iii-221209150910-1d9a7b7c-thumbnail.jpg?width=120&height=120&fit=bounds" /> CASE PRESENTATION ON LEG CELLULITIS

CASE PRESENTATION ON LEG CELLULITIS from CHANDANAC24

]]> 8067 0 https://cdn.slidesharecdn.com/ss_thumbnails/iii-221209150910-1d9a7b7c-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 CASE PRESENTATION ON CHRONIC KIDNEY DISEASE AND URINARY TRACT INFECTION /slideshow/case-presentation-on-chronic-kidney-disease-and-urinary-tract-infection/254841646 iii-221209150538-9b6fdef9
CASE PRESENTATION ON CHRONIC KIDNEY DISEASE AND URINARY TRACT INFECTION CHRONIC KIDNEY DISEASE DEFINITION:- Chronic kidney disease (CKD) is defined by a reduction in the glomerular filtration rate (GFR) and/or urinary abnormalities or structural abnormalities of the renal tract. CKD refers to an irreversible deterioration in renal function that usually develops over a period of years. Initially, manifests only as a biochemical abnormality but, eventually, loss of the excretory, metabolic and endocrine functions of the kidney leads to clinical symptoms and signs of renal failure. ETIOLOGY:- Diabetes mellitus Interstitial diseases Glomerular diseases Hypertension Reno vascular disease Unknown CLINICAL FEATURES:- Polyuria and nocturia Proteinuria Haematuria Hypertension and fluid overload Uraemia Anaemia Electrolyte disturbances URINARY TRACT INFECTION Urinary tract infection refers to the presence of organisms in the urinary tract together with symptoms and signs, of inflammation. Refers to presence or absence, of functional or structural abnormalities within the urinary tract. Infections of the urinary tract can be divided into two general anatomic categories : Lower tract infection (Urethritis, cystitis) Upper tract infection (pyelonephritis) ]]>
CASE PRESENTATION ON CHRONIC KIDNEY DISEASE AND URINARY TRACT INFECTION CHRONIC KIDNEY DISEASE DEFINITION:- Chronic kidney disease (CKD) is defined by a reduction in the glomerular filtration rate (GFR) and/or urinary abnormalities or structural abnormalities of the renal tract. CKD refers to an irreversible deterioration in renal function that usually develops over a period of years. Initially, manifests only as a biochemical abnormality but, eventually, loss of the excretory, metabolic and endocrine functions of the kidney leads to clinical symptoms and signs of renal failure. ETIOLOGY:- Diabetes mellitus Interstitial diseases Glomerular diseases Hypertension Reno vascular disease Unknown CLINICAL FEATURES:- Polyuria and nocturia Proteinuria Haematuria Hypertension and fluid overload Uraemia Anaemia Electrolyte disturbances URINARY TRACT INFECTION Urinary tract infection refers to the presence of organisms in the urinary tract together with symptoms and signs, of inflammation. Refers to presence or absence, of functional or structural abnormalities within the urinary tract. Infections of the urinary tract can be divided into two general anatomic categories : Lower tract infection (Urethritis, cystitis) Upper tract infection (pyelonephritis) ]]> Fri, 09 Dec 2022 15:05:38 GMT /slideshow/case-presentation-on-chronic-kidney-disease-and-urinary-tract-infection/254841646 CHANDANAC24@slideshare.net(CHANDANAC24) CASE PRESENTATION ON CHRONIC KIDNEY DISEASE AND URINARY TRACT INFECTION CHANDANAC24 CASE PRESENTATION ON CHRONIC KIDNEY DISEASE AND URINARY TRACT INFECTION CHRONIC KIDNEY DISEASE DEFINITION:- Chronic kidney disease (CKD) is defined by a reduction in the glomerular filtration rate (GFR) and/or urinary abnormalities or structural abnormalities of the renal tract. CKD refers to an irreversible deterioration in renal function that usually develops over a period of years. Initially, manifests only as a biochemical abnormality but, eventually, loss of the excretory, metabolic and endocrine functions of the kidney leads to clinical symptoms and signs of renal failure. ETIOLOGY:- Diabetes mellitus Interstitial diseases Glomerular diseases Hypertension Reno vascular disease Unknown CLINICAL FEATURES:- Polyuria and nocturia Proteinuria Haematuria Hypertension and fluid overload Uraemia Anaemia Electrolyte disturbances URINARY TRACT INFECTION Urinary tract infection refers to the presence of organisms in the urinary tract together with symptoms and signs, of inflammation. Refers to presence or absence, of functional or structural abnormalities within the urinary tract. Infections of the urinary tract can be divided into two general anatomic categories : Lower tract infection (Urethritis, cystitis) Upper tract infection (pyelonephritis) <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/iii-221209150538-9b6fdef9-thumbnail.jpg?width=120&height=120&fit=bounds" /> CASE PRESENTATION ON CHRONIC KIDNEY DISEASE AND URINARY TRACT INFECTION CHRONIC KIDNEY DISEASE DEFINITION:- Chronic kidney disease (CKD) is defined by a reduction in the glomerular filtration rate (GFR) and/or urinary abnormalities or structural abnormalities of the renal tract. CKD refers to an irreversible deterioration in renal function that usually develops over a period of years. Initially, manifests only as a biochemical abnormality but, eventually, loss of the excretory, metabolic and endocrine functions of the kidney leads to clinical symptoms and signs of renal failure. ETIOLOGY:- Diabetes mellitus Interstitial diseases Glomerular diseases Hypertension Reno vascular disease Unknown CLINICAL FEATURES:- Polyuria and nocturia Proteinuria Haematuria Hypertension and fluid overload Uraemia Anaemia Electrolyte disturbances URINARY TRACT INFECTION Urinary tract infection refers to the presence of organisms in the urinary tract together with symptoms and signs, of inflammation. Refers to presence or absence, of functional or structural abnormalities within the urinary tract. Infections of the urinary tract can be divided into two general anatomic categories : Lower tract infection (Urethritis, cystitis) Upper tract infection (pyelonephritis)

CASE PRESENTATION ON CHRONIC KIDNEY DISEASE AND URINARY TRACT INFECTION from CHANDANAC24

]]> 473 0 https://cdn.slidesharecdn.com/ss_thumbnails/iii-221209150538-9b6fdef9-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 CASE PRESENTATION ON ECLAMPSIA /slideshow/case-presentation-on-eclampsia/254841622 ii-221209150243-ae93d7d7
CASE PRESENTATION ON LATE PRETERM, HYPERBILIRUBINEMIA, ECLAMPSIA]]>
CASE PRESENTATION ON LATE PRETERM, HYPERBILIRUBINEMIA, ECLAMPSIA]]> Fri, 09 Dec 2022 15:02:43 GMT /slideshow/case-presentation-on-eclampsia/254841622 CHANDANAC24@slideshare.net(CHANDANAC24) CASE PRESENTATION ON ECLAMPSIA CHANDANAC24 CASE PRESENTATION ON LATE PRETERM, HYPERBILIRUBINEMIA, ECLAMPSIA <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ii-221209150243-ae93d7d7-thumbnail.jpg?width=120&height=120&fit=bounds" /> CASE PRESENTATION ON LATE PRETERM, HYPERBILIRUBINEMIA, ECLAMPSIA

CASE PRESENTATION ON ECLAMPSIA from CHANDANAC24

]]> 455 0 https://cdn.slidesharecdn.com/ss_thumbnails/ii-221209150243-ae93d7d7-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 CASE PRESENTATION ON HTN,DM,LIMB WEAKNESS /slideshow/case-presentation-on-htndmlimb-weakness/254841583 ii-221209145956-f13bc528
HTN,DM,LIMB WEAKNESS]]>
HTN,DM,LIMB WEAKNESS]]> Fri, 09 Dec 2022 14:59:56 GMT /slideshow/case-presentation-on-htndmlimb-weakness/254841583 CHANDANAC24@slideshare.net(CHANDANAC24) CASE PRESENTATION ON HTN,DM,LIMB WEAKNESS CHANDANAC24 HTN,DM,LIMB WEAKNESS <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ii-221209145956-f13bc528-thumbnail.jpg?width=120&height=120&fit=bounds" /> HTN,DM,LIMB WEAKNESS

CASE PRESENTATION ON HTN,DM,LIMB WEAKNESS from CHANDANAC24

]]> 176 0 https://cdn.slidesharecdn.com/ss_thumbnails/ii-221209145956-f13bc528-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 CASE PRESENTATION ON HTN ,TYPE 2 DM,PANCREATITIS /slideshow/case-presentation-on-htn-type-2-dmpancreatitis/254841562 ii-221209145728-bc778ecf
CASE PRESENTATION ON HTN ,TYPE 2 DM,PANCREATITIS.pptx]]>
CASE PRESENTATION ON HTN ,TYPE 2 DM,PANCREATITIS.pptx]]> Fri, 09 Dec 2022 14:57:28 GMT /slideshow/case-presentation-on-htn-type-2-dmpancreatitis/254841562 CHANDANAC24@slideshare.net(CHANDANAC24) CASE PRESENTATION ON HTN ,TYPE 2 DM,PANCREATITIS CHANDANAC24 CASE PRESENTATION ON HTN ,TYPE 2 DM,PANCREATITIS.pptx <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ii-221209145728-bc778ecf-thumbnail.jpg?width=120&height=120&fit=bounds" /> CASE PRESENTATION ON HTN ,TYPE 2 DM,PANCREATITIS.pptx

CASE PRESENTATION ON HTN ,TYPE 2 DM,PANCREATITIS from CHANDANAC24

]]> 235 0 https://cdn.slidesharecdn.com/ss_thumbnails/ii-221209145728-bc778ecf-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 CASE PRESENTAION ON BRONCHITIS /slideshow/case-presentaion-on-bronchitis/254841536 ii-221209145350-bf8020d2
CASE PRESENTATION ON BRONCHITIS PATIENT DEMOGRAPHIC DETAILS Patient name:-MNN Age:-20yrs Gender:-Male IP no.:-698/698 DOA:-10-01-2017 CHIEF COMPLAINTS ON ADMISSION C/O Fever with chills since 1week C/O Cough since 1week PATIENT HISTORY Patient medication history:-NS Patient medical history:-NS Social history:-NS Family history:-NS Allergies:-NKA ]]>
CASE PRESENTATION ON BRONCHITIS PATIENT DEMOGRAPHIC DETAILS Patient name:-MNN Age:-20yrs Gender:-Male IP no.:-698/698 DOA:-10-01-2017 CHIEF COMPLAINTS ON ADMISSION C/O Fever with chills since 1week C/O Cough since 1week PATIENT HISTORY Patient medication history:-NS Patient medical history:-NS Social history:-NS Family history:-NS Allergies:-NKA ]]> Fri, 09 Dec 2022 14:53:50 GMT /slideshow/case-presentaion-on-bronchitis/254841536 CHANDANAC24@slideshare.net(CHANDANAC24) CASE PRESENTAION ON BRONCHITIS CHANDANAC24 CASE PRESENTATION ON BRONCHITIS PATIENT DEMOGRAPHIC DETAILS Patient name:-MNN Age:-20yrs Gender:-Male IP no.:-698/698 DOA:-10-01-2017 CHIEF COMPLAINTS ON ADMISSION C/O Fever with chills since 1week C/O Cough since 1week PATIENT HISTORY Patient medication history:-NS Patient medical history:-NS Social history:-NS Family history:-NS Allergies:-NKA <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ii-221209145350-bf8020d2-thumbnail.jpg?width=120&height=120&fit=bounds" /> CASE PRESENTATION ON BRONCHITIS PATIENT DEMOGRAPHIC DETAILS Patient name:-MNN Age:-20yrs Gender:-Male IP no.:-698/698 DOA:-10-01-2017 CHIEF COMPLAINTS ON ADMISSION C/O Fever with chills since 1week C/O Cough since 1week PATIENT HISTORY Patient medication history:-NS Patient medical history:-NS Social history:-NS Family history:-NS Allergies:-NKA

CASE PRESENTAION ON BRONCHITIS from CHANDANAC24

]]> 2673 0 https://cdn.slidesharecdn.com/ss_thumbnails/ii-221209145350-bf8020d2-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 CASE PRESENTATION ON ACUTE CORONARY SYNDROME ,ANTERIOR WALL MYOCARDIAL INFARCTION,HYPERTENSION,TYPE-2 DIABETES MELLITUS,MODERATE LV DYSFUNCTION /slideshow/case-presentation-on-acute-coronary-syndrome-anterior-wall-myocardial-infarctionhypertensiontype2-diabetes-mellitusmoderate-lv-dysfunction/251609995 ii-220418170726
CASE PRESENTATION ON ACUTE CORONARY SYNDROME ,ANTERIOR WALL MYOCARDIAL INFERCTION,HYPERTENSION,TYPE-2 DIABETES MELLITUS,MODERATE LV DYSFUNCTION PRESENTED BY:- Chandana C 2nd pharm-D SSCP PATIENT DEMOGRAPHIC DETAILS:- NAME:-Chow…….. AGE:-67years GENDER:-Male WEIGHT:-64Kg HEIGHT:-162cm BMI:-24.4Kg/m2 IP NO.:-19020189 DOA:-14-2-2019 DOD:-16-2-2019 NAME:-Chow…….. AGE:-67years GENDER:-Male WEIGHT:-64Kg HEIGHT:-162cm BMI:-24.4Kg/m2 IP NO.:-19020189 DOA:-14-2-2019 DOD:-16-2-2019 NAME:-Chow…….. AGE:-67years GENDER:-Male WEIGHT:-64Kg HEIGHT:-162cm BMI:-24.4Kg/m2 IP NO.:-19020189 DOA:-14-2-2019 DOD:-16-2-2019 PATIENT HISTORY:- Past medical history:-Type-2 Diabetes mellitus, Hypertension Past medication history:-He didn’t take medication for type 2 diabetes mellitus, on regular prescription for Hypertension Social history:-NS Family history:-NS Allergies:-NKA Diet:-Vegetarian PROVISIONAL DIAGNOSIS:- Acute coronary syndrome –anterior wall myocardial infarction, type 2 diabetes mellitus, hypertension, moderate LV dysfunction FINAL DIAGNOSIS:- Type 2 diabetes mellitus, Hypertension, ACS-AWMI, Moderate LV dysfunction TREATMENT GOALS:- Do PTCA for AWMI Reduce infarct size To reduce signs and symptoms To prevent further complication To reduce morbidity and mortality rate of diabetes mellitus, hypertension, AWMI TREATMENT OPTIONS RECOMMENDED BY CLINICAL PHARMACIST:- Beta blockers:-atenolol, metoprolol Antiplatelet therapy:- ticagrelor, tirofiban, aspirin Potassium channel activator:-nicorandil ACE inhibitors:-Ramipril, captopril Biguanides:-metformin Sulfonylurea:-glimepiride, gliclazide, glipizide HMG COA reductase inhibitors:- atorvastatin, rosuvastatin, simvastatin PROBLEMS IDENTIFIED:- There is no treatment given for diabetes mellitus Heart rate is increased Blood glucose level is elevated PHARMACIST INTERVENSION:- Prescribe medication for diabetes mellitus Advice patient to take medication regularly for diabetes mellitus Reduce heart rate PATIENT COUNSELLING:- ABOUT DISEASE AND MEDICATION :- Educate patient about signs and symptoms and complications of disease Educate about morbidity and mortality Advice to take medication as per prescription Educate about route of administration and time of administration ABOUT LIFESTYLE MODIFICATION Do physical exercise Be physically active Take rest Take medication as per chart ABOUT DIET:- Consume fresh fruits and vegetables Moderate carbohydrate intake Low fat diet and dairy products Reduce sugar and salt intake Advice DASH diet THANK YOU Chandana C, Sree Siddaganga College of Pharmacy 18-04-2019]]>
CASE PRESENTATION ON ACUTE CORONARY SYNDROME ,ANTERIOR WALL MYOCARDIAL INFERCTION,HYPERTENSION,TYPE-2 DIABETES MELLITUS,MODERATE LV DYSFUNCTION PRESENTED BY:- Chandana C 2nd pharm-D SSCP PATIENT DEMOGRAPHIC DETAILS:- NAME:-Chow…….. AGE:-67years GENDER:-Male WEIGHT:-64Kg HEIGHT:-162cm BMI:-24.4Kg/m2 IP NO.:-19020189 DOA:-14-2-2019 DOD:-16-2-2019 NAME:-Chow…….. AGE:-67years GENDER:-Male WEIGHT:-64Kg HEIGHT:-162cm BMI:-24.4Kg/m2 IP NO.:-19020189 DOA:-14-2-2019 DOD:-16-2-2019 NAME:-Chow…….. AGE:-67years GENDER:-Male WEIGHT:-64Kg HEIGHT:-162cm BMI:-24.4Kg/m2 IP NO.:-19020189 DOA:-14-2-2019 DOD:-16-2-2019 PATIENT HISTORY:- Past medical history:-Type-2 Diabetes mellitus, Hypertension Past medication history:-He didn’t take medication for type 2 diabetes mellitus, on regular prescription for Hypertension Social history:-NS Family history:-NS Allergies:-NKA Diet:-Vegetarian PROVISIONAL DIAGNOSIS:- Acute coronary syndrome –anterior wall myocardial infarction, type 2 diabetes mellitus, hypertension, moderate LV dysfunction FINAL DIAGNOSIS:- Type 2 diabetes mellitus, Hypertension, ACS-AWMI, Moderate LV dysfunction TREATMENT GOALS:- Do PTCA for AWMI Reduce infarct size To reduce signs and symptoms To prevent further complication To reduce morbidity and mortality rate of diabetes mellitus, hypertension, AWMI TREATMENT OPTIONS RECOMMENDED BY CLINICAL PHARMACIST:- Beta blockers:-atenolol, metoprolol Antiplatelet therapy:- ticagrelor, tirofiban, aspirin Potassium channel activator:-nicorandil ACE inhibitors:-Ramipril, captopril Biguanides:-metformin Sulfonylurea:-glimepiride, gliclazide, glipizide HMG COA reductase inhibitors:- atorvastatin, rosuvastatin, simvastatin PROBLEMS IDENTIFIED:- There is no treatment given for diabetes mellitus Heart rate is increased Blood glucose level is elevated PHARMACIST INTERVENSION:- Prescribe medication for diabetes mellitus Advice patient to take medication regularly for diabetes mellitus Reduce heart rate PATIENT COUNSELLING:- ABOUT DISEASE AND MEDICATION :- Educate patient about signs and symptoms and complications of disease Educate about morbidity and mortality Advice to take medication as per prescription Educate about route of administration and time of administration ABOUT LIFESTYLE MODIFICATION Do physical exercise Be physically active Take rest Take medication as per chart ABOUT DIET:- Consume fresh fruits and vegetables Moderate carbohydrate intake Low fat diet and dairy products Reduce sugar and salt intake Advice DASH diet THANK YOU Chandana C, Sree Siddaganga College of Pharmacy 18-04-2019]]> Mon, 18 Apr 2022 17:07:25 GMT /slideshow/case-presentation-on-acute-coronary-syndrome-anterior-wall-myocardial-infarctionhypertensiontype2-diabetes-mellitusmoderate-lv-dysfunction/251609995 CHANDANAC24@slideshare.net(CHANDANAC24) CASE PRESENTATION ON ACUTE CORONARY SYNDROME ,ANTERIOR WALL MYOCARDIAL INFARCTION,HYPERTENSION,TYPE-2 DIABETES MELLITUS,MODERATE LV DYSFUNCTION CHANDANAC24 CASE PRESENTATION ON ACUTE CORONARY SYNDROME ,ANTERIOR WALL MYOCARDIAL INFERCTION,HYPERTENSION,TYPE-2 DIABETES MELLITUS,MODERATE LV DYSFUNCTION PRESENTED BY:- Chandana C 2nd pharm-D SSCP PATIENT DEMOGRAPHIC DETAILS:- NAME:-Chow…….. AGE:-67years GENDER:-Male WEIGHT:-64Kg HEIGHT:-162cm BMI:-24.4Kg/m2 IP NO.:-19020189 DOA:-14-2-2019 DOD:-16-2-2019 NAME:-Chow…….. AGE:-67years GENDER:-Male WEIGHT:-64Kg HEIGHT:-162cm BMI:-24.4Kg/m2 IP NO.:-19020189 DOA:-14-2-2019 DOD:-16-2-2019 NAME:-Chow…….. AGE:-67years GENDER:-Male WEIGHT:-64Kg HEIGHT:-162cm BMI:-24.4Kg/m2 IP NO.:-19020189 DOA:-14-2-2019 DOD:-16-2-2019 PATIENT HISTORY:- Past medical history:-Type-2 Diabetes mellitus, Hypertension Past medication history:-He didn’t take medication for type 2 diabetes mellitus, on regular prescription for Hypertension Social history:-NS Family history:-NS Allergies:-NKA Diet:-Vegetarian PROVISIONAL DIAGNOSIS:- Acute coronary syndrome –anterior wall myocardial infarction, type 2 diabetes mellitus, hypertension, moderate LV dysfunction FINAL DIAGNOSIS:- Type 2 diabetes mellitus, Hypertension, ACS-AWMI, Moderate LV dysfunction TREATMENT GOALS:- Do PTCA for AWMI Reduce infarct size To reduce signs and symptoms To prevent further complication To reduce morbidity and mortality rate of diabetes mellitus, hypertension, AWMI TREATMENT OPTIONS RECOMMENDED BY CLINICAL PHARMACIST:- Beta blockers:-atenolol, metoprolol Antiplatelet therapy:- ticagrelor, tirofiban, aspirin Potassium channel activator:-nicorandil ACE inhibitors:-Ramipril, captopril Biguanides:-metformin Sulfonylurea:-glimepiride, gliclazide, glipizide HMG COA reductase inhibitors:- atorvastatin, rosuvastatin, simvastatin PROBLEMS IDENTIFIED:- There is no treatment given for diabetes mellitus Heart rate is increased Blood glucose level is elevated PHARMACIST INTERVENSION:- Prescribe medication for diabetes mellitus Advice patient to take medication regularly for diabetes mellitus Reduce heart rate PATIENT COUNSELLING:- ABOUT DISEASE AND MEDICATION :- Educate patient about signs and symptoms and complications of disease Educate about morbidity and mortality Advice to take medication as per prescription Educate about route of administration and time of administration ABOUT LIFESTYLE MODIFICATION Do physical exercise Be physically active Take rest Take medication as per chart ABOUT DIET:- Consume fresh fruits and vegetables Moderate carbohydrate intake Low fat diet and dairy products Reduce sugar and salt intake Advice DASH diet THANK YOU Chandana C, Sree Siddaganga College of Pharmacy 18-04-2019 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ii-220418170726-thumbnail.jpg?width=120&height=120&fit=bounds" /> CASE PRESENTATION ON ACUTE CORONARY SYNDROME ,ANTERIOR WALL MYOCARDIAL INFERCTION,HYPERTENSION,TYPE-2 DIABETES MELLITUS,MODERATE LV DYSFUNCTION PRESENTED BY:- Chandana C 2nd pharm-D SSCP PATIENT DEMOGRAPHIC DETAILS:- NAME:-Chow…….. AGE:-67years GENDER:-Male WEIGHT:-64Kg HEIGHT:-162cm BMI:-24.4Kg/m2 IP NO.:-19020189 DOA:-14-2-2019 DOD:-16-2-2019 NAME:-Chow…….. AGE:-67years GENDER:-Male WEIGHT:-64Kg HEIGHT:-162cm BMI:-24.4Kg/m2 IP NO.:-19020189 DOA:-14-2-2019 DOD:-16-2-2019 NAME:-Chow…….. AGE:-67years GENDER:-Male WEIGHT:-64Kg HEIGHT:-162cm BMI:-24.4Kg/m2 IP NO.:-19020189 DOA:-14-2-2019 DOD:-16-2-2019 PATIENT HISTORY:- Past medical history:-Type-2 Diabetes mellitus, Hypertension Past medication history:-He didn’t take medication for type 2 diabetes mellitus, on regular prescription for Hypertension Social history:-NS Family history:-NS Allergies:-NKA Diet:-Vegetarian PROVISIONAL DIAGNOSIS:- Acute coronary syndrome –anterior wall myocardial infarction, type 2 diabetes mellitus, hypertension, moderate LV dysfunction FINAL DIAGNOSIS:- Type 2 diabetes mellitus, Hypertension, ACS-AWMI, Moderate LV dysfunction TREATMENT GOALS:- Do PTCA for AWMI Reduce infarct size To reduce signs and symptoms To prevent further complication To reduce morbidity and mortality rate of diabetes mellitus, hypertension, AWMI TREATMENT OPTIONS RECOMMENDED BY CLINICAL PHARMACIST:- Beta blockers:-atenolol, metoprolol Antiplatelet therapy:- ticagrelor, tirofiban, aspirin Potassium channel activator:-nicorandil ACE inhibitors:-Ramipril, captopril Biguanides:-metformin Sulfonylurea:-glimepiride, gliclazide, glipizide HMG COA reductase inhibitors:- atorvastatin, rosuvastatin, simvastatin PROBLEMS IDENTIFIED:- There is no treatment given for diabetes mellitus Heart rate is increased Blood glucose level is elevated PHARMACIST INTERVENSION:- Prescribe medication for diabetes mellitus Advice patient to take medication regularly for diabetes mellitus Reduce heart rate PATIENT COUNSELLING:- ABOUT DISEASE AND MEDICATION :- Educate patient about signs and symptoms and complications of disease Educate about morbidity and mortality Advice to take medication as per prescription Educate about route of administration and time of administration ABOUT LIFESTYLE MODIFICATION Do physical exercise Be physically active Take rest Take medication as per chart ABOUT DIET:- Consume fresh fruits and vegetables Moderate carbohydrate intake Low fat diet and dairy products Reduce sugar and salt intake Advice DASH diet THANK YOU Chandana C, Sree Siddaganga College of Pharmacy 18-04-2019

CASE PRESENTATION ON ACUTE CORONARY SYNDROME ,ANTERIOR WALL MYOCARDIAL INFARCTION,HYPERTENSION,TYPE-2 DIABETES MELLITUS,MODERATE LV DYSFUNCTION from CHANDANAC24

]]> 461 0 https://cdn.slidesharecdn.com/ss_thumbnails/ii-220418170726-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Hypertension, Ischemic Heart Disease, Diabetes Mellitus- Case Presentation /slideshow/hypertension-ischemic-heart-disease-diabetes-mellitus-case-presentation/251580933 ii-220413172231
CASE PRESENTATION ON TYPE-II DIABETES MELLITUS, ISCHAEMIC HEART DISEASE WITH HYPERTENSION Presented by:- CHANDANA C 2nd PHARM.D SREE SIDDAGANGA COLLEGE OF PHARMACY Chief Complaints on admission:- Hyperglycemia and chest pain Provisional Diagnosis:- Diabetes mellitus with Ischemic Heart Disease Final Diagnosis:- Type-II Diabetes mellitus , Ischaemic Heart Disease with Hypertension Treatment goals:- To relieve signs and symptoms To prevent the complication To prevent the progression of the disease To achieve the targeted BP To reduce hypertension, diabetes mellitus ,ischaemic heart disease morbidity and mortality Problems Identified:- Failure to receive the drugs Overdose Sub therapeutic Route of administration Dose frequency Goals achieved:- Reduction in BP Pharmacotherapy initiated to control hypertension , diabetes mellitus Symptoms are reduced Monitoring parameters:- Vitals(BP,HR,PR) Serum creatinine RBS(Random glucose test) Hematological analysis ECG Adverse drug reaction Patient Counselling:- About disease:- Educate the patient about Control Risk factors Complications THANK YOU]]>
CASE PRESENTATION ON TYPE-II DIABETES MELLITUS, ISCHAEMIC HEART DISEASE WITH HYPERTENSION Presented by:- CHANDANA C 2nd PHARM.D SREE SIDDAGANGA COLLEGE OF PHARMACY Chief Complaints on admission:- Hyperglycemia and chest pain Provisional Diagnosis:- Diabetes mellitus with Ischemic Heart Disease Final Diagnosis:- Type-II Diabetes mellitus , Ischaemic Heart Disease with Hypertension Treatment goals:- To relieve signs and symptoms To prevent the complication To prevent the progression of the disease To achieve the targeted BP To reduce hypertension, diabetes mellitus ,ischaemic heart disease morbidity and mortality Problems Identified:- Failure to receive the drugs Overdose Sub therapeutic Route of administration Dose frequency Goals achieved:- Reduction in BP Pharmacotherapy initiated to control hypertension , diabetes mellitus Symptoms are reduced Monitoring parameters:- Vitals(BP,HR,PR) Serum creatinine RBS(Random glucose test) Hematological analysis ECG Adverse drug reaction Patient Counselling:- About disease:- Educate the patient about Control Risk factors Complications THANK YOU]]> Wed, 13 Apr 2022 17:22:31 GMT /slideshow/hypertension-ischemic-heart-disease-diabetes-mellitus-case-presentation/251580933 CHANDANAC24@slideshare.net(CHANDANAC24) Hypertension, Ischemic Heart Disease, Diabetes Mellitus- Case Presentation CHANDANAC24 CASE PRESENTATION ON TYPE-II DIABETES MELLITUS, ISCHAEMIC HEART DISEASE WITH HYPERTENSION Presented by:- CHANDANA C 2nd PHARM.D SREE SIDDAGANGA COLLEGE OF PHARMACY Chief Complaints on� admission:- Hyperglycemia and chest pain Provisional �Diagnosis:- Diabetes mellitus with Ischemic Heart Disease Final Diagnosis:- Type-II Diabetes mellitus , Ischaemic Heart Disease with Hypertension Treatment goals:- To relieve signs and symptoms To prevent the complication To prevent the progression of the disease To achieve the targeted BP To reduce hypertension, diabetes mellitus ,ischaemic heart disease morbidity and mortality Problems Identified:- Failure to receive the drugs Overdose Sub therapeutic Route of administration Dose frequency Goals achieved:- Reduction in BP Pharmacotherapy initiated to control hypertension , diabetes mellitus Symptoms are reduced Monitoring parameters:- Vitals(BP,HR,PR) Serum creatinine RBS(Random glucose test) Hematological analysis ECG Adverse drug reaction Patient Counselling:- About disease:- Educate the patient about Control Risk factors Complications THANK YOU <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ii-220413172231-thumbnail.jpg?width=120&height=120&fit=bounds" /> CASE PRESENTATION ON TYPE-II DIABETES MELLITUS, ISCHAEMIC HEART DISEASE WITH HYPERTENSION Presented by:- CHANDANA C 2nd PHARM.D SREE SIDDAGANGA COLLEGE OF PHARMACY Chief Complaints on� admission:- Hyperglycemia and chest pain Provisional �Diagnosis:- Diabetes mellitus with Ischemic Heart Disease Final Diagnosis:- Type-II Diabetes mellitus , Ischaemic Heart Disease with Hypertension Treatment goals:- To relieve signs and symptoms To prevent the complication To prevent the progression of the disease To achieve the targeted BP To reduce hypertension, diabetes mellitus ,ischaemic heart disease morbidity and mortality Problems Identified:- Failure to receive the drugs Overdose Sub therapeutic Route of administration Dose frequency Goals achieved:- Reduction in BP Pharmacotherapy initiated to control hypertension , diabetes mellitus Symptoms are reduced Monitoring parameters:- Vitals(BP,HR,PR) Serum creatinine RBS(Random glucose test) Hematological analysis ECG Adverse drug reaction Patient Counselling:- About disease:- Educate the patient about Control Risk factors Complications THANK YOU

Hypertension, Ischemic Heart Disease, Diabetes Mellitus- Case Presentation from CHANDANAC24

]]> 506 0 https://cdn.slidesharecdn.com/ss_thumbnails/ii-220413172231-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 CASE PRESENTATION ON HYPERTENSION, TYPE 2 DIABETES MELLITUS,CEREBRO VASCULAR ACCIDENT /slideshow/case-presentation-on-hypertension-type-2-diabetes-mellituscerebro-vascular-accident/251509440 ii-220404151217
CASE PRESENTATION ON HYPERTENSION, TYPE 2 DIABETES MELLITUS,CEREBRO VASCULAR ACCIDENT PATIENT DEMOGRAPHIC DETAILS:- NAME:-AXAB AGE:60yrs GENDER:- Male IP NO.:-18110362 DOA:-25-11-18 DOC:-30-11-2018 BMI:-25.2kg/m² CHIEF COMPLAINTS:- C/o Hiccups from 5 days with sensation of both UL and LL since 3 days , Chest discomfort, Left side weakness PATIENT HISTORY:- PAST MEDICAL HISTORY:-k/c/o Type 2 diabetes mellitus PAST MEDICATION HISTORY:-on prescription since 10 yrs. SOCIAL HISTORY:-Alcoholic FAMILY HISTORY:-NS ALLERGIES:-NKA DIET:-Veg PROVISIONAL DIAGNOSIS:- TYPE 2 DIABETES MELLITUS AND HYPERTENSION PHARMACEUTICAL CARE PLAN:- SOAP ANALYSIS:- TREATMENT GOAL:- 1.Reduce chief complaints 2.Reduce morbidity and mortality 3. Reduce weight 4. reduce infarct size TREATMENT OPTIONS:- 1.ORAL HYPOGLYCEMIC AGENT:- Metformin , glimepiride, tenegliptin 2.ANTIHYPERTENSIVE AGENTS:-ACE inhibitors, ARB s 3. ANTINEUROPATHI AGENTS:-diazepam 4. NSAID s 5.ANTIPLATELET DRUGS PROBLEMS IDENTIFIED:- There is no laboratory data for chest discomfort There is proper long term discharge medication for hypertension There is so many drugs for diabetes it may leads to polypharmacy PHARMACIST INTERVENSION:- 1.Suggest to conduct lab test for chest discomfort 2. Suggest to prescribe long term medication for hypertension 3.Suggest to reduce drugs for diabetes mellitus PATIENT COUNSELLING:- 1.Reduce weight 2.Avoid fatty food and alcohol 3.Intake more fiber rich food like berries, cereals… 4.Be physically active 5.Do physical exercise and walking 6.Reduce stress 7.Take medication properly 8.Regular check-ups THANK YOU Abbreviations:- LL: Lower Limb UL: Upper Limb MRI: Magnetic Resonance Imaging GRBS: Generalized Random Blood Sugar PBS: Post Prandial Blood Sugar NS: Nothing Significant NKA: Nil Known Allergies yrs: Years veg: Vegetarian ACE: Angiotensin Converting Enzyme ARB: Angiotensin Receptor Blocker NSAID: Non Steroidal Anti Inflammatory Drugs These slides provides you information about the case presentation at the basic level of SOAP analysis. This is the live patient's case and we holds confidentiality about the patient's demographic details. This provides an exercising case analysis for the beginners. ]]>
CASE PRESENTATION ON HYPERTENSION, TYPE 2 DIABETES MELLITUS,CEREBRO VASCULAR ACCIDENT PATIENT DEMOGRAPHIC DETAILS:- NAME:-AXAB AGE:60yrs GENDER:- Male IP NO.:-18110362 DOA:-25-11-18 DOC:-30-11-2018 BMI:-25.2kg/m² CHIEF COMPLAINTS:- C/o Hiccups from 5 days with sensation of both UL and LL since 3 days , Chest discomfort, Left side weakness PATIENT HISTORY:- PAST MEDICAL HISTORY:-k/c/o Type 2 diabetes mellitus PAST MEDICATION HISTORY:-on prescription since 10 yrs. SOCIAL HISTORY:-Alcoholic FAMILY HISTORY:-NS ALLERGIES:-NKA DIET:-Veg PROVISIONAL DIAGNOSIS:- TYPE 2 DIABETES MELLITUS AND HYPERTENSION PHARMACEUTICAL CARE PLAN:- SOAP ANALYSIS:- TREATMENT GOAL:- 1.Reduce chief complaints 2.Reduce morbidity and mortality 3. Reduce weight 4. reduce infarct size TREATMENT OPTIONS:- 1.ORAL HYPOGLYCEMIC AGENT:- Metformin , glimepiride, tenegliptin 2.ANTIHYPERTENSIVE AGENTS:-ACE inhibitors, ARB s 3. ANTINEUROPATHI AGENTS:-diazepam 4. NSAID s 5.ANTIPLATELET DRUGS PROBLEMS IDENTIFIED:- There is no laboratory data for chest discomfort There is proper long term discharge medication for hypertension There is so many drugs for diabetes it may leads to polypharmacy PHARMACIST INTERVENSION:- 1.Suggest to conduct lab test for chest discomfort 2. Suggest to prescribe long term medication for hypertension 3.Suggest to reduce drugs for diabetes mellitus PATIENT COUNSELLING:- 1.Reduce weight 2.Avoid fatty food and alcohol 3.Intake more fiber rich food like berries, cereals… 4.Be physically active 5.Do physical exercise and walking 6.Reduce stress 7.Take medication properly 8.Regular check-ups THANK YOU Abbreviations:- LL: Lower Limb UL: Upper Limb MRI: Magnetic Resonance Imaging GRBS: Generalized Random Blood Sugar PBS: Post Prandial Blood Sugar NS: Nothing Significant NKA: Nil Known Allergies yrs: Years veg: Vegetarian ACE: Angiotensin Converting Enzyme ARB: Angiotensin Receptor Blocker NSAID: Non Steroidal Anti Inflammatory Drugs These slides provides you information about the case presentation at the basic level of SOAP analysis. This is the live patient's case and we holds confidentiality about the patient's demographic details. This provides an exercising case analysis for the beginners. ]]> Mon, 04 Apr 2022 15:12:17 GMT /slideshow/case-presentation-on-hypertension-type-2-diabetes-mellituscerebro-vascular-accident/251509440 CHANDANAC24@slideshare.net(CHANDANAC24) CASE PRESENTATION ON HYPERTENSION, TYPE 2 DIABETES MELLITUS,CEREBRO VASCULAR ACCIDENT CHANDANAC24 CASE PRESENTATION ON HYPERTENSION, TYPE 2 DIABETES MELLITUS,CEREBRO VASCULAR ACCIDENT PATIENT DEMOGRAPHIC DETAILS:- NAME:-AXAB AGE:60yrs GENDER:- Male IP NO.:-18110362 DOA:-25-11-18 DOC:-30-11-2018 BMI:-25.2kg/m² CHIEF COMPLAINTS:- C/o Hiccups from 5 days with sensation of both UL and LL since 3 days , Chest discomfort, Left side weakness PATIENT HISTORY:- PAST MEDICAL HISTORY:-k/c/o Type 2 diabetes mellitus PAST MEDICATION HISTORY:-on prescription since 10 yrs. SOCIAL HISTORY:-Alcoholic FAMILY HISTORY:-NS ALLERGIES:-NKA DIET:-Veg PROVISIONAL DIAGNOSIS:- TYPE 2 DIABETES MELLITUS AND HYPERTENSION PHARMACEUTICAL CARE PLAN:- SOAP ANALYSIS:- TREATMENT GOAL:- 1.Reduce chief complaints 2.Reduce morbidity and mortality 3. Reduce weight 4. reduce infarct size TREATMENT OPTIONS:- 1.ORAL HYPOGLYCEMIC AGENT:- Metformin , glimepiride, tenegliptin 2.ANTIHYPERTENSIVE AGENTS:-ACE inhibitors, ARB s 3. ANTINEUROPATHI AGENTS:-diazepam 4. NSAID s 5.ANTIPLATELET DRUGS PROBLEMS IDENTIFIED:- There is no laboratory data for chest discomfort There is proper long term discharge medication for hypertension There is so many drugs for diabetes it may leads to polypharmacy PHARMACIST INTERVENSION:- 1.Suggest to conduct lab test for chest discomfort 2. Suggest to prescribe long term medication for hypertension 3.Suggest to reduce drugs for diabetes mellitus PATIENT COUNSELLING:- 1.Reduce weight 2.Avoid fatty food and alcohol 3.Intake more fiber rich food like berries, cereals… 4.Be physically active 5.Do physical exercise and walking 6.Reduce stress 7.Take medication properly 8.Regular check-ups THANK YOU Abbreviations:- LL: Lower Limb UL: Upper Limb MRI: Magnetic Resonance Imaging GRBS: Generalized Random Blood Sugar PBS: Post Prandial Blood Sugar NS: Nothing Significant NKA: Nil Known Allergies yrs: Years veg: Vegetarian ACE: Angiotensin Converting Enzyme ARB: Angiotensin Receptor Blocker NSAID: Non Steroidal Anti Inflammatory Drugs These slides provides you information about the case presentation at the basic level of SOAP analysis. This is the live patient's case and we holds confidentiality about the patient's demographic details. This provides an exercising case analysis for the beginners. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ii-220404151217-thumbnail.jpg?width=120&height=120&fit=bounds" /> CASE PRESENTATION ON HYPERTENSION, TYPE 2 DIABETES MELLITUS,CEREBRO VASCULAR ACCIDENT PATIENT DEMOGRAPHIC DETAILS:- NAME:-AXAB AGE:60yrs GENDER:- Male IP NO.:-18110362 DOA:-25-11-18 DOC:-30-11-2018 BMI:-25.2kg/m² CHIEF COMPLAINTS:- C/o Hiccups from 5 days with sensation of both UL and LL since 3 days , Chest discomfort, Left side weakness PATIENT HISTORY:- PAST MEDICAL HISTORY:-k/c/o Type 2 diabetes mellitus PAST MEDICATION HISTORY:-on prescription since 10 yrs. SOCIAL HISTORY:-Alcoholic FAMILY HISTORY:-NS ALLERGIES:-NKA DIET:-Veg PROVISIONAL DIAGNOSIS:- TYPE 2 DIABETES MELLITUS AND HYPERTENSION PHARMACEUTICAL CARE PLAN:- SOAP ANALYSIS:- TREATMENT GOAL:- 1.Reduce chief complaints 2.Reduce morbidity and mortality 3. Reduce weight 4. reduce infarct size TREATMENT OPTIONS:- 1.ORAL HYPOGLYCEMIC AGENT:- Metformin , glimepiride, tenegliptin 2.ANTIHYPERTENSIVE AGENTS:-ACE inhibitors, ARB s 3. ANTINEUROPATHI AGENTS:-diazepam 4. NSAID s 5.ANTIPLATELET DRUGS PROBLEMS IDENTIFIED:- There is no laboratory data for chest discomfort There is proper long term discharge medication for hypertension There is so many drugs for diabetes it may leads to polypharmacy PHARMACIST INTERVENSION:- 1.Suggest to conduct lab test for chest discomfort 2. Suggest to prescribe long term medication for hypertension 3.Suggest to reduce drugs for diabetes mellitus PATIENT COUNSELLING:- 1.Reduce weight 2.Avoid fatty food and alcohol 3.Intake more fiber rich food like berries, cereals… 4.Be physically active 5.Do physical exercise and walking 6.Reduce stress 7.Take medication properly 8.Regular check-ups THANK YOU Abbreviations:- LL: Lower Limb UL: Upper Limb MRI: Magnetic Resonance Imaging GRBS: Generalized Random Blood Sugar PBS: Post Prandial Blood Sugar NS: Nothing Significant NKA: Nil Known Allergies yrs: Years veg: Vegetarian ACE: Angiotensin Converting Enzyme ARB: Angiotensin Receptor Blocker NSAID: Non Steroidal Anti Inflammatory Drugs These slides provides you information about the case presentation at the basic level of SOAP analysis. This is the live patient's case and we holds confidentiality about the patient's demographic details. This provides an exercising case analysis for the beginners.

CASE PRESENTATION ON HYPERTENSION, TYPE 2 DIABETES MELLITUS,CEREBRO VASCULAR ACCIDENT from CHANDANAC24

]]> 1217 0 https://cdn.slidesharecdn.com/ss_thumbnails/ii-220404151217-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://cdn.slidesharecdn.com/profile-photo-CHANDANAC24-48x48.jpg?cb=1698943688 https://cdn.slidesharecdn.com/ss_thumbnails/drugdisposalbrochure-221209153907-dfad09fc-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/drug-disposal-brochure-254841937/254841937 Drug disposal brochure https://cdn.slidesharecdn.com/ss_thumbnails/iv-221209153247-1fcc2c8e-thumbnail.jpg?width=320&height=320&fit=bounds CHANDANAC24/seizuretype-ii-diabetes-meliitus SEIZURE,TYPE II DIABET... https://cdn.slidesharecdn.com/ss_thumbnails/iv-221209153130-d66435a1-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/gastroenteritis-254841833/254841833 GASTROENTERITIS